ArticleCell reports. Medicine2023

Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response.

Rong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.